Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 6,154,152 |
|
|||||
| News | - | ||||||
| Day High | 129.25 | Low High |
|||||
| Day Low | 128.0269 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.63 | -0.49% | 128.66 | 19:41:16 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 129.25 | 128.0269 | 129.25 | 128.66 | 129.29 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 76,272 | 6,154,152 | $ 128.46 | $ 790,591,967 | - | 99.14 - 133.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:45:53 | 1 | $ 129.00 | USD |
Merck (MRK) Options Flow Summary
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 325.87B | - | - | - | 142.85 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 127.01 | 131.51 | 127.01 | 129.91 | 7,083,977 | 1.65 | 1.30% |
| 1 Month | 126.005 | 132.80 | 124.50 | 128.39 | 7,238,304 | 2.66 | 2.11% |
| 3 Months | 128.19 | 133.10 | 119.41 | 126.25 | 8,267,577 | 0.47 | 0.37% |
| 6 Months | 102.83 | 133.10 | 99.80 | 118.82 | 8,378,385 | 25.83 | 25.12% |
| 1 Year | 116.78 | 133.10 | 99.14 | 113.71 | 7,752,163 | 11.88 | 10.17% |
| 3 Years | 79.06 | 133.10 | 70.89 | 94.27 | 9,865,641 | 49.60 | 62.74% |
| 5 Years | 77.62 | 133.10 | 65.25 | 88.68 | 9,950,050 | 51.04 | 65.76% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. |
